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ABSTRACT: Renibacterium salmoninarum, the causative agent of bacterial kidney disease, produces
large quantities of a 57-58 kDa protein (p57) during growth in broth culture and during infection of
salmonid fish. Biological activities of secreted p57 include agglutination of salrnonid leucocytes and
rabbit erythrocytes. We define the location of epitopes on p57 recognized by agglutination-blocking
monoclonal antibodies (MAbs) 4Cl1, 4H8 and 4D3, and demonstrate that the majority of secreted p57
is a nlonomer that retains salrnonid leucocyte agglutinat~ngactivity. The 3 MAbs bound a recombinant,
amino-terminal fragment of p57 (211 aa) but not a carboxy-terminal fragment (315 aa) demonstrating
that the neutralizing epitopes are located within the amino-terminal portion of p57. When combinations
of the MAbs were used in an antigen capture ELISA. the epitopes recognized by the 3 MAbs were
shown to be sterically separate. However, when the same MAb was used as both the coating and detection MAb, binding of the biotinylated detection MAb was not observed. These data indicate that the
epitopes recognized by the 3 agglutination-blocking antibodies are functionally available only once
per molecule and that native p57 exists as a monomer Similar ELISA results were obtained when kidney tissues from 3 naturally infected chinook salmon were assayed. Finally, a p57 monomer was purified using anion exchange and size exclusion chromatography that retained in vitro agglutinating
activity. A model in which p57 is released from R. salmoninarum as a biologically active monomer
during infection of salmonid fish is proposed.

KEY WORDS: Bacterial kidney disease - Renibacterium salmoninarum . Monoclonal antibody
Agglutination . Epitope

INTRODUCTION
Bacterial kidney disease is a chronic, systemic, granulomatous, and often fatal disease prevalent among
juvenile and adult salmonids (Fryer & Sanders 1981).
Bacterial kidney disease is one of the most difficult
bacterial diseases to control in salmonid aquaculture
facilities due in part to 2 unusual pathogenic mechanisms of the causative agent, Renibacterium salmoninarum (Elliott et al. 1989). First, R. salmoninarum can
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be vertically transmitted from female fish to offspring
via intracellular infection of the egg (Evelyn et al. 1984,
1986). Second, the bacterium can reside intracellularly
within salmonid phagocytes and other host cells which
may hinder immune clearance (Young & Chapman
1978, Bruno & Munro 1986, Gutenberger et al. 1997,
McIntosh et al. 1997). Little is known about the molecular mechanisms of pathogenesis or the host immune
response (Evenden et al. 1993), however, this knowledge is crucial for the development of more efficacious
therapeutics and vaccines.
The best characterized virulence factor of Renibacterium salmoninarum is a 57-58 kDa protein (p57).
This protein is exposed on the bacterial cell surface of
most strains and is also abundantly secreted by the
bacteria during growth in culture media or infection of
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fish (Getchell et al. 1985, Turaga et al. 1987b, Wiens &
Kaattari 1989, Rockey et al. 1991a, Bandin et al. 1992).
Cell-assoc~atedp57 has been reported to be necessary
for virulence as spontaneous mutants of R. salmoninarum lacking cell-associated p57 were less virulent
upon intraperitoneal challenge (Bruno 1988, 1990).
However, whether these mutants completely lack expression of p57 has been questioned (Grayson et al.
1995).
The function of secreted p57 in pathogenesis is
unclear and sequence comparison with other proteins
has so far been uninformative. P57 is a glycine rich,
557 amino acid protein containing 2 copies of a n 81
residue direct repeat, which are 60% homologous, and
5 copies of a second 25 residue imperfect repeat
(Chien et al. 1992). One function of p57 may be to
mediate adherence of the bacteria to host tissues. P57
has been reported to form a fimbrial structure on the
bacterial cell surface and has a number of other characteristics of bacterial adhesins including haemagglutinating activity, a n acidic isoelectric point, and hydrophobic amino acid composition (Jones & Isaacson 1983,
Daly & Stevenson 1990, Dubreuil et al. 1990a, Wiens &
Kaattari 1991). In vitro, the secreted form of p57 has
immunomodulatory effects as it is able to bind and
agglutinate salmonid leucocytes and suppress antibody production to the unrelated antigens, trinitrophenylated lipopolysaccharide and human gammaglobulin (Turaga et al. 1987a, Rockey et al. 1991b, and
Wiens & Kaattari 1991, Fredriksen et al. 1997). In addition, injection of coho salmon eggs with p57 has been
reported to result in long term irnmunosuppression
(Brown et al. 1996).
We have previously identified functional domains of
p57 using a panel of 8 anti-p57 monoclonal antibodies
(MAbs) (Wiens & Kaattari 1991). Three of the MAbs
(4D3, 4H8, and 4Cl l ) inhibit haemagglutinating
activity while 2 of these MAbs (4H8 and 4 C l l ) inhibit
the leucoagglutinating activity of p57. The 3 agglutination inhibiting MAbs, referred to as group I MAbs,
putativly recognize epitopes located on the aminoterminal third of p57, as determined by amino acid
sequenclng of p57 and immunoblotting of partial p57
proteolytic digests. Group I1 MAbs (3H1 and 2G5)
recognize epitopes located in the central region of p57,
while group I11 MAbs (1Al,4D10 and 2G9A) recognize
epitopes present in the carboxy-terminal third of p57
that are not exposed when intact p57 is attached to the
Renibactenum salmoninarum cell surface.
In this study, the functional domains of p57 were further defined. The group I MAbs recognized separate
non-overlapping epitopes in an enzyme linked immunosorbent assay (ELISA) and these epitopes were
localized on the amino-terminal portion of p57 by
irnmunoblotting of recombinant fragments of p57. The

subunit structure of p57 was also examined with fast
pressure liquid chromatography (FPLC) and ELISA
and we found that secreted p57 was present as a
monomer in culture supernatant as well as infected
fish tissue. The monomer, purified from bacterial culture supernatant, was sufficient for agglutination of
rabbit erythrocytes and fish leucocytes in vitro.

MATERIALS AND METHODS
Animals. Rainbow trout Oncorhynchus mykiss were
held in 12°C well water at the Oregon State University
Salmon Disease Laboratory and were fed Oregon
Moist Pellets (Bioproducts, Warrington, OR). Samples
of infected ludney tissue were obtained from spawning
spring chinook salmon (0. tshawytscha) at Marion
Forks Hatchery, OR, and Carson Hatchery, WA, and
homogenized as previously described (Rockey et al.
1991a).
Purification of MAbs. Cell-free ascites fluid from
group I MAbs (4Cl1, 4H8, and 4D3), group I1 MAbs
(2G5 and 3H1) and group 111 MAbs (1Al and 4D10)
were collected and purified by protein A chromatography as described previously (Wiens & Kaattari 1991).
Protein content was determined by the method of
Lowry et al. (1951).
Extracellular protein (ECP) concentration. Renibacterium salmoninarum ATCC 33209 extracellular protein was harvested from medium and concentrated as
described previously (Wiens & Kaattari 1991).The predominant component of ECP prepared in this manner
is p57 with associated proteolytic degradation fragments (Rockey et al. 1991b, Wiens & Kaattari 1991).
Total protein was assessed by the method of Lowry et
al. (1951)using bovine serum albumin (BSA, Sigma, St.
Louis, MO) as a standard. The ECP was filter-sterilized
(0.45 pm) and stored at -70°C or kept at 4°C for immediate use.
ELISA. A capture ELISA was performed as described
previously (Wiens & Kaattari 1989). Briefly, in this
assay 5 pg ml-' MAbs 4D3. 4H8, 4Cl1, or polyclonal
rabbit anti-ECP were separately coated onto the plate,
non-specific sites blocked with 1 % BSA - 0.1 %
Tween-Tris buffered saline (TTBS; 50 mM Tris, 1 mM
EDTA, 8.7% NaCl, pH 8.0), and then 5 pg ml-' ECP in
0.1% TTBS was added. After washing the wells, 5 pg
ml-' of a biotinylated detection MAb was added as a
probe to screen for available epitopes on p57. Streptavidin-horseradish peroxidase (Sigma) was then added
to determine the amount of bound biotinylated antibody. To measure non-specific binding, biotinylated
MOPC-21, a l g G , , ~MAb of unknown specificity, was
used as a negative control (Sigma). Formalin-fixed
Renibacfenum salmoninarum cells were used as a
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positive control to show that aggregates of p57 could
be detected by the ELISA. R. salmoninarum cells were
fixed for 12 h with 0.3 % formalin, washed 3x in phosphate buffered saline (10 mM, PBS, pH 7.21, and
resuspended at a concentration of 50 1-19 wet wt ml-'
of 1 % BSA in 0.1 % TTBS.
Purification of p57. FPLC was used to purify p57
from ECP. Prior to FPLC, ECP was dialyzed in 50 mM
phosphate buffer (pH 7.2) and filtered through a 0.2 pm
low protein binding filter (Acrodisc 13, Gelman Sciences, Ann Arbor, MI). Approximately 3.9 mg of protein was loaded onto a HR 5/5 Mono Q anion exchange
column and eluted with a biphasic salt gradient of 0 to
0.6 M NaC1, followed by 0.G to 1.0 M NaCl in 50 mM
phosphate buffer (pH 7.2).One milliliter fractions from
the anion exchange column were stored at -70°C until
analyses were performed. A biphasic salt gradient
eluted approximately 70% of the total protein in fractions 1 to 30 (see Fig. 3A).
To determine the native molecular weight of p57,
fraction 6 (75 pg total protein) from the anion exchange
column was separated on a HR 10/30 Superose 12
FPLC gel filtration column (10 X 30 cm, Pharmacia)
using a buffer of 50 mM NaCl, 50 mM phosphate
(pH 7.2) and 1 mM phenylmethylsulfonyl fluoride protease inhibitor (PMSF). The peak absorbing fraction
(15) from the gel filtration column was concentrated
12-fold by ultrafiltration using a Centricon-3 (3000 MW
cutoff, Amicon Division, Grace and Co., CT).
Protease assay. The protease assay adapted from
Sarath et al. (1989) used filter sterilized substrate solution of 2 O/o azoalbumin (Sigma)in a 0.1 % sodium dodecyl sulfate, 10 mM phosphate, 7.5% NaCl buffer
(pH 7.2). Protease activity was determined by mixing
30 p1 of each column fraction with 50 p1 of substrate at
an incubation temperature of 37°C for 15 h. Intact substrate was precipitated with 200 p1 of 10% tnchloroacetic acid for 15 min at room temperature. Samples
were microfuged for 5 min, and 100 p1 of supernatant
was transferred to ELISA wells to which 100 p1 1.0 M
NaOH was added. The A,,, (absorbance at 450 nm)
was determined using an EIA autoreader (Biotek
Instruments, Burlington, VT). Units of activity were
calculated from a log-log plot using trypsin (#T2271,
Bovine Pancreas, Sigma) as a standard.
Leucoagglutination and haemagglutination assays.
Rainbow trout leucocytes and rabbit erythrocytes were
prepared as previously described (Wiens & Kaattari
1991), except that leucocytes were resuspended to a
final concentration of 2 % autologous plasma (DeKoning & Kaattari 1991) instead of 10 % fetal bovine serum.
Agglutination reactions worked equally well in either
serum source. A total of 1.0 X 106 leucocytes well-' or
1.5 X 106 erythrocytes well-' were mixed with 50 p1 of
column fraction or 2-fold dilutions of each fraction.
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Agglutination was assessed after 24 h by microscopic
examination.
Construction and expression of recombinant, truncated p57 fragments. A 636 nt EcoRI to XhoI fragment
encoding amino acids 32 to 243 of p57 was subcloned
into PET-22b(+) (Novagen, Madison, WI). A second
construct containing the carboxy-terminal amino acids
242 to 557 was generated by PCR amplification with
the reverse primer 5'-CGCGCTCGAGGTTAAAGGTAATATCTAT and a forward primer 5'-CCGACAGCAACTCTCGAGCCT. Hot start PCR amplification was
carried out as recommended (Perkin Elmer, Norwalk,
CT) using 5U of Ultma polymerase and 750 ng of target
DNA. Twenty an~plificationcycles (94"C, 30 S; 55"C,
2 mini 72"C, 3 min) were followed by 10 min at 72°C.
Following PCR, the product was purified and digested
with XhoI and the 946 b p fragment subcloned into PET
22b(+) expression vector and confirmed by sequencing. Both constructs were expressed according to
the protocol supplied with the pET22b(+) vector
(Novagen). Briefly, the constructs were transformed
into E. coli BL 21 and grown to an O.D. of 0.6 (600 nm).
The expression of the His-tag fusion proteins was
induced with 1 mM IPTG for 2 h. Bacterial cells were
washed in 50 mM Tris, pH 8.0,2 mM EDTA, and stored
as a pellet at -70°C. Thawed cells were resuspended
1:4 wt: v01 in 50 mM Tris, pH 8.0, 2 mM EDTA, and
40 1.11 of this suspension was mixed with 10 p1 1 M DTT
and 50 p1 2x SDS-PAGE sample buffer. Samples were
boiled for 3 min, and sonicated for 2 s (Heat System
Ultra Sonicator Inc.). Standard 10 or 12% SDS-PAGE
and Western blotting were performed as previously
described using the Mini-PROTEAN I1 system (BioRad) (Wiens et al. 1990).

RESULTS
Epitope identification using group I MAbs
In order to characterize the functional domains of
p57 we used an antigen capture ELISA to determine if
the epitopes recognized by the group I antibodies are
distinct. Results from these experiments indicated that
each of the 3 MAbs recognized spatially distinct
epitopes (Fig. lA,B,C). For example, when 4D3 was
coated onto wells, both heterologous biotinylated antibodies 4H8 (4H8-B), 4 C l l - B as well as polyclonal
rabbit antisera (RB-B) bound to p57, while the
homologous antibody (4D3-B) and negative control
MAb MOPC 21-B did not bind (Fig. 1A). Analogous
results were obtained using the 4H8 and 4 C l l MAbs
(Fig. lB,C). Some binding of 4 C l l - B to p57 captured
by 4 C l l was observed, but was apparently nonspecific in nature as the level was similar to that ob-
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served using the negative control antibody MOPC21-B.
Equivalent activity of each biotinylated antibody was
demonstrated by its binding to ECP coated wells
(Fig. ID).

Expression of a recombinant p57
To independently localize the epitopes recognized
by the group I MAbs, the amino-terminal portion of
p57 and a carboxy-terminal portion of p57 were
expressed in E. coli BL21 with a pel-B leader and Histag (Fig. 2A). The amino terminal fragment, designated p57.NH2, contained amino acids 32 to 243 and
included amino acid repeat A l . The carboxy-terminal
fragment of p57, designated p57.COOH, contained
amino acids 242 to 557 including amino acid repeat
A2 and repeats B1-5. Expression of p57.NH2 and
p57.COOH in E. coli was induced with IPTG and
detected by Coomassie Blue staining of SDS-PAGE
gels (Fig. 2B). MAb recognition of the recombinant
proteins was assessed by immunoblotting. Group I
MAb, 4H8, bound the amino-terminal fragment
(Fig. 2B, lane 2), but not the carboxy-terminal fragment
(lane 3). MAbs 4C11 and 4D3 showed a similar binding
pattern (data not shown). Lack of binding to the car-

Coated with 4 D 3
2.0

w.w

4H8-B 4CI 1-6 4D3-B RE-E MOPC-B
Capture Antibody

".V

Coated with 4 C l l

2.07

u.u

2.0
fi

boxy-terminal fragment containing repeat A2 suggests
that the group I antibodies do not recognize shared
epitopes located on repeat A1 and A2. Conversely,
group I1 (MAb 2G5) and group I11 (MAb 1Al) antibodies recognized epitopes on the carboxy-terminal
fragment (Fig. 2B, lane 3) but not the amino-terminal
fragment (lane 2). MAbs 3H1 and 4D10 showed a
similar binding pattern (data not shown). The expression of p57.COOH produced several immunoreactive
bands that presumably represent proteolytic degradation products consistent with the previously observed
proteolysis of recombinant p57 expressed in E. coli
(Grayson et al. 1995).

Purification of p57 from culture supernatant and
analysis of agglutinating activity
To determine the subunit structure of p57 we used
chromatographic methods to purify p57 from ECP.
First, ECP was separated on an anion exchange monoQ column. The majority of protein was eluted in the
first 5 fractions as determined by absorbance at 280 nm
(Fig. 3A). P57 was the major component eluting in
fractions 5 through 14 as determined by total protein
staining of transblotted proteins from SDS-PAGE gels

Coated with 4H8

,

l

4H8-B 4Cll-B 4D3-B RB-B MOPC-B
Capture Antibody

,

Coated with E C P

-

".U

4H8-B 4CI 1-6 4D3-B RB-B MOPC-B
Capture Antibody

4H8-B 4CI I-B 4D3-B RE-B MOPC-B
Capture Antibody

Fig. 1. ELISA epitope analysis using
combinations of arouD I MAbs. 4D3.
4H8, and 4Cl l . Antidody was coated
onto the ELISA plate at 5 pg mlF1 followed by 5 pg ml-' ECP diluted in 0.1 %
TTBS. Biotinylated detection MAbs
(5 pg ml-l,MAb-B) were used to determine the steric availabhty of epitopes.
B~otinylatedrabbit anti-ECP sera (RB-B)
was used as a positive control, and biotinylated MAb MOPC 21 (MOPC-B)
was used as a negative control to detect
nonspecific binding. ECP was coated
d~rectlyonto the ELISA plate to determine maximal binding of each biotinylated antibody. After substrate
was added, plates were incubated for
30 rnin before AdOS
was measured. Error
bars denote standard deviations of
tnplicate wells S d a r results were
obtained in 3 separate experiments
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(Fig. 3B). The identity of p57 in these fractions was
further confirmed by Western blotting using MAb 1Al
(Fig. 4B) and MAb 4D3 (not shown). Column fractions were also tested for haemagglutinating activity,
proteolytic activity, and immunoreactivity by ELISA.
Fractions 4 through 15 possessed haemagglutinating
activity correlating with the elution of p57 (Fig. 4A).
Proteolytic activity, detected by azoalbumin degradation, was also observed in ECP and a major peak of
activity eluted in fraction 3 prior to fractions in which
the majority of p57 was found (Fig. 4A). In addition,
minor amounts of proteolytic activity were observed in
fractions 10 through 15. Proteolytic activity was undetectable in fraction 6 which was used for further
molecular weight characterization.
To determine the native molecular weight of p57,
75 pg of fraction 6 from the anion exchange column
was subjected to superose size exclusion chromatography. Dextran blue (30 pg) was included as an
internal marker. Two peaks were detected by A280
absorbance, the first peak was dextran blue at 7.5 m1
and the second peak eluted at a peak of 14.3 m1
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Flg 2. (A) Linear depiction of native p57 protein including
repeated regions. The larger repeat consists of two 81
residues segments A1 and A2, and the smaller repeated
sequence consists of 5 non-identical repeats of approximately 25 residues each (B1 through B5). Two fragments of
p57 were expressed from a PET-22b vector in E. coli strain
BL21. An amino-terminal fragment from amino acid 32 to
243 (p57.NH2) and a carboxy-fragment from amino acid 232
to 557 (p57.COOH). (B) Immunoblots and Coomassie blue
stain of recombinant proteins probed with either group I
MAb 4H8, group I1 MAb 2G5, or group I11 MAb 1 A l . Lanes
after the molecular weight markers are as follows: 1, 1 pg
ECP. 2, p57.NH2, 3, p57.COOH, 4 , Induced E. coh control.
Intact p57 is identified with a n arrow

Fig. 3. (A) FPLC anion-exchange chron~atographyof concentrated culture supernatant (ECP) from Renlbacterium salrnoninarum ATCC 33209. ECP (proteln content 3.9 mg) was
applied to a anion-exchange Mono-Q column (HR 5/5) and
eluted with a biphasic NaCl gradient in a 50 mM phosphate
buffer (pH 7.2; flow rate 1 m1 m ~ n - ' )The
.
protein content of
the eluent was detected photometrically at 280 nm with a UV
monitor (solid line). A linear salt gradient of 0 to 600 mM was
used to elute proteins from fraction 6 to 28 (dotted h e ) . A 600
to 1000 mM salt gradient was used from fraction 28 to 32.
(B) Total protein stain of FPLC anion exchange column fractions 2 through 26. A total of 2.5 p1 of each fraction was
electrophoresed through a 10% SDS polyacrylamide gel and
electroblotted onto nitrocellulose and total protein detected
with a collodial gold stain. The results are representative of
2 experiments

(Fig. 5A). The second peak contained p57 as determined by a highly sensitive ELISA, and the majority of
immunoreactivity eluted in fractions 14 through 17.
Estimation of relative n~olecularweight of p57 using a
panel of known proteins indicated that p57 eluted as
a monomer with a calculated relative migration of
46500 Da (Fig. 5B), as opposed to a dimer or multiaggregated protein which should have eluted prior to
fraction 13. Fraction 15 was further concentrated and
subject to electrophoresis and immunoblotting (Fig. 6).
P57 was purified to near homogeneity (Fig. 6 , lane 3),
excluding a small amount of p45, as compared to the
starting material (Fig. 6, lane 1).The minimum concentration required for agglutinating activity of rainbow
trout leucocytes was decreased from 25 pg ml-' of the
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approximately 2-fold increase in act~vity.Agglutination of rabbit erythrocytes was also observed with purified p57. Agglutinating activity could be completely
blocked with 100 pg ml-' MAb 4H8 confirming that
agglutination was mediated by p57.
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Capture ELISA analysis of p57 in infected fish tissues

0.0

5

0

15

10

20

25

30

35

Fraction (ml)

B

Fraction
2

S

7

9 12 14 16 18 19 20 22 24 26

Fig. 4. Agglutinating, proteolytic, and irnrnunoreactive properties of the anion-exchange column fractions. (A) Fractions
with agglutinating activity for rabbit erythrocytes are indicated with a +. Column fractions were coated onto ELISA
wells and immunoreactivity probed with MAb 1 A l (e). Proteolytic activity against azoalbumin was measured as described in 'Materials and methods' (0). (B) Western blot of
column fractions using MAb 1 A l . Intact p57 IS identified with
an arrow

To investigate whether monomers of p57 were present in infected fish tissue, we performed capture
ELISA analysis on kidney homogenates from naturally
infected adult chinook salmon. Similar to the analysis
shown in Fig. 1, p57 captured by MAb 4D3 was not
recognized by the homologous biotinylated MAb 4D3
but was recognized by the heterologous MAb 4H8-B
(Fig. 7). Formalin-fixed bacteria were used as a positive control to demonstrate that the combination of
MAb 4D3 and 4D3-B could detect aggregates of p57. It
is unclear why MAb 4D3-B showed less binding to the
formalin-fixed bacterial cells at concentrations equivalent to those used with MAb 4H8-B, but perhaps this
was due to steric hindrance from the coating MAb 4D3
or destruction of epitopes by formalin.

DISCUSSION

To elucidate the molecular mechanisms of Renibacterium salmoninarumpathogenesis, we utilized mouse
M A to~ characterize
~
the structure and function of a
major cell surface and secreted protein, p57. In this
study1 we extend our previous epitope map of ~5~ and
investigate the m.echanism of cell agglutination. Previ-
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Fig. 5. (A) Size exclusion chromatography of anion exchange fraction number 6 (75 pg), using a Superose 12 column. Dextran
blue (30 pg) was included as a n internal standard. (B) Relative migration of proteins vs log molecular weight markers. The column
was equilibrated with 50 mM phosphate and 50 mM NaCl, pH 7.2, and Sigma standards were used to calibrate the column. Each
point represents the average elution time and standard deviation calculated from 3 separate experiments. Standards included
dextran blue ( 2 000 OOO), thryoglobulin (669OOO), bovine serum albumin (66 OOO), ovalbumin (43 OOO), carbonic anhydrase (29000)
and cytochrome C (12400).The dashed Line represents the calculated molecular weight for p57. Identical results were obtained
with 2 separate p57 preparations
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Fig. 6 . Immunoblot of column purified p57. The immunoblot
was probed with 1 pg ml-' of a pool of purified MAbs 4D3,
3H1, and 1Al. Primary MAb was detected by a 1:4000 goat
anti-mouse Ig HRPO conjugate. The blot was developed with
a chenlilunlinescent substrate (Amersham)and exposed to f~lm
for 1 min. Lanes: 1, ECP, 1 pg; 2, 2.5 p1 of FPLC Mono-Q fraction 6 ; 3, 7.5 p1 of 12x concentrated Superose 12 fraction 15

ously, we found that 3 MAbs, 4H8, 4 C l l and 4D3,
inhibit haemagglutinating activity while 2 of these
MAbs, 4H8 and 4Cl l also inhibit the leucoagglutinating activity of p57 (Wiens & Kaattari 1991). To determine if these antibodies recognize the same or distinct
epitopes on p57 we used a capture ELISA. In this

Probed with:
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4H8-8
MOPC21-B

V)

0
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05

DD
ECP

R S Cells

Fish 1

Fish 2

Fish 3

Coated with MAb 4D3

Fig. 7. ELISA epitope analysis of kidney tissue from 3 infected
adult chinook salmon which were previously found to have
antigen levels above 1 pg ml-' Plates were coated with 5 pg
rnl-' 4D3, blocked with 1 % BSA-TTBS, and either 5 pg ml-'
ECP, formalin-fixed Renibacterium sa1moninaru:n cells (50 pg
ml-l), or a 1:100 dilution of kidney tissue homogenate added.
ELISA plates were then probed with 5 pg ml-' detection MAbs
4D3-B, 4H8-B or MOPC21-B. After substrate was added,
plates were incubated for 10 min before
was measured.
Error bars denote standard deviations of triplicate wells

49

assay, MAb 4D3, 4Cl l and 4H8 each recognized a distinct epitope. The locations of the 4D3, 4H8 and 4 C l l
epitopes were confirmed to lie between amino acids 32
to 243 on p57 as all 3 of the MAbs bound the recombinant, amino-terminal fragment, p57.NH2, but
not to the carboxy-terminal fragment, p57.COOH, in a
Western blot. These findings are consistent with our
previous data showing that group I MAbs bind aminoterminal proteolytic fragments of p57 (Wiens & Kaattari 1991). Also consistent with our previous epitope
map, group I1 MAbs (2G5 and 3 H l ) and group 111
MAbs (1Al and 4D10) bound p57.COOH but not
p57.NH2. The demonstration that the 3 group I MAbs
recognized separate epitopes, and that these epitopes
are separate from epitopes bound by the group I1 or 111
antibodies, may have relevance for MAb-based immunodiagnostic assays used to detect p57 in infected
salmonids (Hsu et al. 1991, Rockey et al. 1991a).Inclusion of individual or combinations of these MAbs
would increase the number of epitopes detected and
may thereby increase the sensitivity of these ELISAs.
The capture ELISA assay revealed an interesting
aspect of the antigenic structure of p57. We observed
that when the same MAb was used for both the coating
and detection, binding of the biotinylated detection
MAb was not observed. This was not due to a failure of
the coating antibody to bind p57 because the heterologous biotinylated MAbs and biotinylated rabbit polyclonal antisera each bound well. This result was the
same with each of the 3 group I MAbs suggesting that
each epitope was functionally available only once per
molecule of p57. These data are consistent with a
monomer structure of p57. A dimer or aggregate of p57,
containing 2 or more copies of the same epitope, would
allow the simultaneous binding of both the homologous coating and detecting antibody, providing that
the epitopes are not masked by dimerization or aggregation. Our failure to detect binding when homologous
MAbs were used was not due to an inability to detect
aggregates of p57 as 4D3 and biotinylated 4D3 were
able to bind formalin-fixed Renibacteriurn salmoninarum cells that contain multiple copies of p57. The
absence of repeated epitopes was surprising as Barton
et al. (1997) have recently reported aggregation of p57
occurred after separation by SDS-PAGE and elution
with SDS and Triton X-100. In addition, we have observed MAb immunoreactive bands much larger than
57 kDa in ECP preparations resolved under reducing
SDS-PAGE conditions (Wiens & Kaattari 1991). It is
possible that the capture ELISA assay was unable to
detect small amounts of p57 aggregates in ECP, or perhaps denaturing conditions are necessary for aggregation. P57 has been described to form short, flexible,
< 2 nm diameter fimbriae that extend beyond the polysaccharide capsule (Dubreuil et al. 1990a,b).Presently,
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the relationship between fimbrae, cell associated p57,
and the secreted p57 in ECP is unclear. The monomers
in ECP may result from proteolysis or unfolding of a
dimer or multimer on the bacterial cell surface.
To independently determine the native molecular
weight of p57 in the absence of apparent denaturation,
p57 was purified from ECP using ion-exchange and
size exclusion chromatography. P57 was partially purified and eluted with a M, of 46 500 consistent with a
monomeric structure. The estimated relative molecular
mass was smaller than the molecular mass of 54 505 Da
calculated from the amino acid sequence of the mature
protein (Chien et al. 1992). The reason for this discrepancy is unknown. A small amount of p45 breakdown
product was present (Fig. 6, lane 3), however, the
majority of p57 in our analysis appears identical to p57
in unfractionated ECP by Western blot, suggesting
that difference in migration was not d u e to extensive
proteolysis during purification. Possibly p57 exhibits
a compact structure under nondenaturing conditions.
Secondary amino acid structure prediction supports
this possibility as p57 is composed of predominatly
beta-regions with little alpha-helix (unpubl. data).
Since a number of agglutinins are multimeric structures, yet p57 eluted as a monomer, the biological
activity was tested in both haemagglutination and
leucoagglutination assays. In vitro addition of the partially purified p57 monomer to rainbow trout leucocytes and rabbit erythrocytes was sufficient to cause
agglutination and the activity was increased 2-fold by
purification. The small increase in biological activity
after purification was not unexpected as p57 is the
major component of Renihactenum salmoninarum ECP
(Getchell et al. 1985, Wiens & Kaattari 1991, Barton et
al. 1997). The agglutinating activity was specific to p57
as it was blocked by MAb 4H8. Interestingly, capture
ELISA analysis suggested that a monomer was also the
predominant from of p57 in kidney homogenates from
3 naturally-infected adult chinook salmon. From these
data we propose a model of p57 in which, at least
initially, a monomer is sufficient to initiate agglutinating activity and is released by R. salmoninarum during
in vivo infection.
Assuming that p57 agglutinates cells in a receptorspecific manner, we propose 3 potential mechanisms
of p57 monomer-mediated agglutination. In the first
mechainsm, p57 may initially be a monomer but may
dimerize or aggregate after binding to a eucaryotic cell
receptor. The binding site on p57 is likely located on
the amino-terminal portion of p57 as MAbs that block
agglutination bind this region. Once initial binding
to the leucocyte occurs, the carboxy-region could be
exposed. The exposed portions of p57 on adjacent
leucocytes or erythrocytes might then dimerize or
multimerize resulting in agglutination. While there is

no direct evidence of the carboxy-region facilitating
aggregation, p57 can aggregate after exposure to
denaturing conditions (Barton et al. 1997).In, addition,
secreted p57 is capable of reassembly onto the Renibacterium salmoninarum cell surface (Daly & Stevenson 1990, Piganelli et al. 1999a). The carboxy-terminal
portion has been implicated in attachment to the bacterial cell surface as partial proteolysis of p57 leaves
carboxy-terminal fragments but not amino-terminal
fragments associated with the bacterium (Wiens &
Kaattari 1991).
A second possible mechanism of monomer-mediated
agglutination may be via proteolysis of host cell
surface receptors. Haemagglutinins from both Vibrio
cholerae and Pseudornonas aeruginosa have zinc/calcium dependent proteolytic activity that is able to
modify erythrocyte surfaces and thereby induce agglutination (Hase & Finkelstein 1990). This mechanism
requires p57 to posess proteolytic activity. Lynch and
collegues have demonstrated that p57, and several
lower molecular weight products of p57, continue to
degrade during 2-dimensional electrophoretic separation of ECP (Gnffiths & Lynch 1991, Barton et al. 1997).
Furthermore, p57, and degradation products of p57
isolated from the WC strain of Renibacterium salrnoninarum, comigrate with PMSF-sensitive proteolytic
activity detected by gelatin substrate gels. Taken
together these results suggests that p57 is autoproteolytic (Barton et al. 1997). Sequence analysis of p57 is
consistent with this possibility as there is homology
between the second repeated region of p57 and both
trypsin-like and V8 staphylococcal-type serine proteases (Chien et al. 1992). In addition, a consensus
serine protease motif G-X-S-X-G has been located
from Gly-406 and Gly-4 10 between repeats B2 and B3
(Fig. 2A) (Grayson et al. 1995). We however have previously failed to detect autoproteolytic activity of p57
purified by isoelectric focusing from the ATCC 33209
and D6 strains (Rockey et al. 1991b),though as Barton
et al. (1997)point out, this could be due to inactivation
of proteolytic activity during isoelectric focusing. While
we did not initially design these experiments to investigate the autoproteolytic activity of p57, our main
finding was that agglutinating activity did not elute
with azoalbumin proteolytic activity suggesting that
the azoalbumin proteolytic activity is a distinct molecule from p57. In addition, the agglutinating activity of
ECP was not inhibited by PMSF or EDTA suggesting
that neither serine nor divalent cation dependent proteolytic activity is required for agglutination (G. D.
Wiens unpubl. data). The presence of a protease in
ECP separate from p57 is consistent with our previous
observations that ECP incubated at 37°C contains a
molecule of >l00 kDa that is PMSF-sensitive with proteolytic activity but no detectable p57 (Rockey et al.
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1991). In addition, the n ~ o l e c u l e having proteinase
activity h a d a n isoelectric point b e t w e e n 6.5 a n d 7.5
which is distinct from t h e 4.5 isoelectric point of p57
(Rockey e t al. 1991). In summary, our d a t a a r g u e
against a protease d e p e n d e n t model of agglutination,
though t h e role of the G-X-S-X-G serine protease motif
in agglutination remains to b e formally tested by sitedirected mutagenesis.
A third mechanism w h e r e b y p57 agglutinates cells
m a y b e via t h e recognition a n d cross-linking of differe n t cellular receptors. It is possible that 2 s e p a r a t e
agglutinating domains exist, e a c h specific for a s e p a rate receptor. Results from t h e a n t i g e n c a p t u r e ELISA
provides potential evidence for this model a s M A b s
4 C l l a n d 4H8,which a r e a b l e to inhibit leucoagglutinating activity, bind to s e p a r a t e epitopes. Superantig e n s , m a n y which a r e produced by Gram-positive bacteria, h a v e s u c h bifunctional properties a n d a r e a b l e to
bind a n d crosslink both major histocompatibility class
I1 molecules a n d T cell receptors (Seth e t al. 1994). P57
is unlike other superantigens from Gram-positive bacteria a s , to our knowledge, superantigens from G r a m positive bacteria d o not agglutinate erythrocytes
(Johnson e t al. 1991). Support for this mechanism
awaits analysis of t h e mitogenic activity of purified p57
a n d t h e identification of t h e leucocyte surface receptor(s).
In summary, w e demonstrate that agglutination-neutralizing g r o u p I MAbs recognize s e p a r a t e epitopes o n
t h e amino-terminal portion of p57 a n d that a m o n o m e r
is t h e predominant subunit structure of p57 in E C P a n d
in infected fish tissue. T h e role of t h e monmeric p57 in
pathogensis is unclear. O n e cellular target of p57 m a y
b e salmonid leukocytes w h e r e it m a y d o w n regulate
i m m u n e function of t h e salmonid host leading to a nonproductive response. In support of this possibility, p57
inhibits specific antibody production in vitro (Turaga e t
a l . 1987a, Rockey et al. 1991b, a n d Wiens & Kaattari
1991, Fredriksen e t al. 1997) a n d injection of p57 into
coho salmon e g g s results in long term immunosuppression (Brown e t al. 1996). T h e p r e s e n c e of bacterial
cell-associated p57 is also likely to b e critical in
pathogensis a s t h e creation of p57- cells by t h e activation of a n e n d o g e n o u s PMSF-senstive protease leads
to a n increased humoral response toward carbohyd r a t e moieties o n t h e bacterial cell surface (Wood &
Kaattari 1996, Piganelli e t al. 1999a). In addition,
results from preliminary vaccine trials using 37°C
treated Renibacterium salmoninarum cells suggest
that t h e removal of p57 is critical for t h e induction of
protective immunity in salmonids (Piganelli e t al.
1999b). T h e future analysis of p 5 7 mutants should
facilitate t h e characterization of functional domain(s)
a n d may clarify h o w t h e presence of p57 impairs t h e
development of protective immunity in salmonids.
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